Hepatocyte transplantation
- PMID: 31663360
- DOI: 10.17235/reed.2019.6270/2019
Hepatocyte transplantation
Abstract
We have read with great interest the study by Vera MC et al. on the intrasplenic transplantation of hepatocytes from donors receiving the carcinogenic drugs diethylnitrosamine (DEN) and 2-actylaminofluorene (2-AAF). The most important conclusion of the study is that there were no signs of tumor progression in the recipient liver at seven and 60 days after hepatocellular transplantation and no differences were found in the animals with healthy hepatocyte transplants.
Comment on
-
First approaches for the transplantation of hepatocytes from Wistar rat preneoplastic livers into healthy recipients.Rev Esp Enferm Dig. 2019 May;111(5):351-357. doi: 10.17235/reed.2019.5830/2018. Rev Esp Enferm Dig. 2019. PMID: 30767553
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources